pharmaceutical
The Latest
-
AbbVie Signs Exclusive Licensing Deal With Sirona Biochem For Breakthrough Compound
AbbVie acquired the license to commercialize and market Sirona’s TFC-1067 compound as part of its expansion into the cosmetics space. 
AbbVie acquired the license to commercialize and market Sirona’s TFC-1067 compound as part of its expansion into the cosmetics space. -
Regeneron Shares Dip Amid $1.1 Billion Cancer Drug Deal
Regeneron's shares dropped by 4.3% to 630.70 per share after it announced its $1.1 billion deal with Sanofi. 
Regeneron's shares dropped by 4.3% to 630.70 per share after it announced its $1.1 billion deal with Sanofi. -
Moderna And Novavax Working On One-Shot Flu And COVID-19 Combo Vaccine
Moderna and Novavax are separately developer single-shot vaccines that will be effective against both COVID-19 and the flu. 
Moderna and Novavax are separately developer single-shot vaccines that will be effective against both COVID-19 and the flu. -
Nasdaq-Listed BeiGene To Be A Star On The Shanghai Board
The offering is expected in the first half of next year. It will be the world's first pharmaceutical firm to be listed on three stock exchanges. 
The offering is expected in the first half of next year. It will be the world's first pharmaceutical firm to be listed on three stock exchanges. -
Eli Lilly Stock Price Jumps After It Requested FDA Approval For Its COVID-19 Treatment
The treatment has reportedly proven effective in reducing COVID-19 symptoms that resulted in patients being hospitalized. 
The treatment has reportedly proven effective in reducing COVID-19 symptoms that resulted in patients being hospitalized. -
AstraZeneca Will Know By Year’s End If Vaccine Protects Against Coronavirus – If Trials Resume
AstraZeneca suspended late-stage trials on its potential vaccine this week after an illness in a participant. 
AstraZeneca suspended late-stage trials on its potential vaccine this week after an illness in a participant. -
Coronavirus: Africa’s CDC Calls On United Worldwide Effort To Defeat COVID-19
"We are in this together. No country will be safe if another still has cases of COVID," the ACDCP said Thursday. 
"We are in this together. No country will be safe if another still has cases of COVID," the ACDCP said Thursday. -
Johnson & Johnson Cuts Prices For TB Drug Amid Pandemic
Johnson & Johnson is slashing the price for its tuberculosis drug bedaquiline to bolster its usage amid the global pandemic. 
Johnson & Johnson is slashing the price for its tuberculosis drug bedaquiline to bolster its usage amid the global pandemic. -
AstraZeneca To Supply Europe With Newly Developed Covid-19 Vaccine
AstraZeneca has reached an agreement with the Inclusive Vaccine Alliance, a group formed by EU-member countries, to supply it with up to 400 million doses of its newly developed coronavirus vaccine. 
AstraZeneca has reached an agreement with the Inclusive Vaccine Alliance, a group formed by EU-member countries, to supply it with up to 400 million doses of its newly developed coronavirus vaccine. -
AstraZeneca Said To Be In Talks With Gilead Over Possible Merger
British-Swedish biotech firm AstraZeneca reportedly approached Gilead Sciences last month, proposing a possible merger deal. 
British-Swedish biotech firm AstraZeneca reportedly approached Gilead Sciences last month, proposing a possible merger deal.
